Aua Capital Management, LLC Neurocrine Biosciences Inc Transaction History

Aua Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$106.72 - $127.06 $1,387 - $1,651	-13 Closed	0 $0
Q2 2021 Jul 29, 2021	BUY	$89.43 - $102.27 $89 - $102	1 Added 8.33%	13 $1,000
Q4 2020 Feb 09, 2021	BUY	$86.91 - $108.33 $260 - $324	3 Added 33.33%	12 $1,000
Q3 2020 Nov 12, 2020	BUY	$96.16 - $135.15 $865 - $1,216	9 New	9 $1,000

625

94.2M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Aua Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Aua Capital Management, LLC with notifications on news.